Abstract
The subject of this paper is pharmaceutical companies and the risk factors that occur in the distribution of drugs. The paper will present guidelines for the risk management of changes in the environment of pharmaceutical distribution channels. To identify, analyse, and prioritise risks, we used a systematic literature review and the Delphi method. Identification and assessment of important risk factors in drug distribution channels were conducted based on opinions of experts from 10 international pharmaceutical companies operating in Southeast Europe. The purpose of the research was to get opinions from experts about the impacts of the risk factors on the distribution of drugs, which was accomplished through interviews and questionnaires that were conducted. Our study demonstrated a total of 78 risk factors in the distribution channels of drugs and pharmaceutical services. The results of the research combined separate evaluations for risk factors in all categories for easier data analysis. After data were obtained, results were arranged to show which risk factors had the biggest influence upon the distribution of drugs and to determine the negative effects they can produce. The research of risks was done primarily to help the representatives of distribution channels gain better insight into drug distribution.
Highlights
The uncertainty of drug and medical service distribution channels is conditioned by the dynamic and complex market and pharmaceutical environment that leads to the realisation of new trends, new products, and services in a short time frame
This study demonstrated a total of 78 risk factors in the distribution channels of drugs and pharmaceutical services (Table A1 shows the risk factors identified in the drug distribution channels of 10 different companies)
The purpose of introducing this analysis was primarily to reduce the negative effects of risk when organising and managing the distribution channels of pharmaceutical companies
Summary
The uncertainty of drug and medical service distribution channels is conditioned by the dynamic and complex market and pharmaceutical environment that leads to the realisation of new trends, new products, and services in a short time frame. Drug distribution today faces some of the toughest challenges in the market [1], such as the growth of new viruses and diseases, new drugs, use of advanced technologies, and increased customer demands. All these challenges generate risks that affect the sustainability of drug distribution, and it is necessary to provide effective support for the pharmaceutical industry. Pharmaceutical companies must follow the development of technologies that will increase the chances of penetrating new markets [3] to fulfil requirements and maintain the sustainable development of the drug industry
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
